Welcome to the July edition of BioMatrix Abstract!
BioMatrix Specialty Infusion Pharmacy
BioMatrix is a trusted specialty pharmacy to patients, prescribers, pharmaceutical manufacturers and payers nationwide.
BioMatrix Abstract informs readers of our leading efforts in the specialty infusion pharmacy space while providing updates on relevant legislative efforts, research initiatives, and current events in healthcare.
DISCLAIMER: THIS IS NOT MEDICAL OR LEGAL ADVICE. All information, content, and material is for informational purposes only and is not intended to serve as a substitute for the consultation, diagnosis, and/or medical treatment of a qualified physician or healthcare provider or as legal advice. Please consult a physician or other health care professional for your specific health care and/or medical needs or concerns and never disregard professional medical advice or delay in seeking it because of something you have read here or on our website.
The New Bully on the Insurance Playground: Alternative Funding Programs
In the ever-changing health insurance landscape, policies do as they always have and change. The new bully on the insurance playground in 2024 are Alternative Funding Programs, or AFPs. Let’s take a look at AFPs and see how you might encounter them in your own health insurance plan.
AlayaCare Named Technology Platform of Choice by BioMatrix Specialty Infusion Pharmacy
To bring nursing and agency documentation all in one place and increase operational efficiency, we've chosen AlayaCare as our technology platform. Read how we're leveraging this software to continue to provide top-notch infusion nursing services.
Interested in Getting Started with BioMatrix?
I am a Patient
Throughout every step of your treatment journey, we are committed to your success. Whether you're looking for infusion medication, infusion nursing, or have questions about your insurance, we're here to help.
I am a Provider
From prescription intake through insurance authorization, medication delivery, and nursing services, we work with you and your team to support your patients’ success. Get started by submitting a referral.
BioMatrix on the Move!
Upcoming Events
Catch up with BioMatrix at this upcoming event. We can't wait to see you!
BioMatrix Was Proud to Attend and Support These Meetings
Thanks to all who participated!
Recommended by LinkedIn
Home Infusion
We administer in-home treatment to provide a more comfortable and convenient infusion experience. The result is safe, consistent, and compassionate treatment for our patients with nursing needs.
Our clinical teams have extensive training and experience in rare diseases, infusion therapies, and complex medical conditions. Our nursing staff coordinates with pharmacists, healthcare providers, and other caregivers ensuring the best treatment outcomes possible.
Where appropriate, our in-home nursing team trains patients to administer their own injectable or infusible drugs, fostering more independence. After the home visit and administration, our nurses also guide patients on continuing with their therapy, help minimize or manage side effects, and answer questions that patients may have throughout their treatment plan.
Whether you're looking for infusion medication, infusion nursing, or have questions about your insurance, we're here to help.
PBMs
A recent FTC report claims that PBMs lean heavily on their market power to profit off of patients and independent pharmacies. The interim report states that “unchecked consolidation” has increased drug prices through the PBM’s market influence. The Top 3 PBMs—CVS Caremark, Cigna Express Scripts, and United Health OptumRx—who control almost 80% of the market are about to be sued by the FTC for anti-trust issues, according to a Wall Street Journal article.
PBMs Exert “Substantial Influence” Over Industry, According to FTC Report
FTC Prepares to Sue Top 3 PBMs
ACA
In investigating ACA plan enrollment, The House of Representatives raised concerns that brokers lie about enrollee’s incomes in order to achieve maximum subsidies from benchmark plans. Nine states have subsidy enrolled individuals that exceed the number of potential enrollees, with Florida evidencing four times as many enrollees as are eligible.
House Investigates ACA Enrollees and Subsidy Eligibility
Specialty Pharmacy
Factor One Support, also known as InfuCare, settled for just over half a million dollars with the Equal Employment Opportunity Commission (EEOC) in a disability and genetic information discrimination lawsuit. The lawsuit claimed that the specialty pharmacy violated the Americans with Disabilities Act (ADA) and the Genetic Information Nondiscrimination Act (GINA) when the pharmacy asked prospective employees about their hemophilia, their children’s hemophilia, and medications they or their children took.
Factor One Support/InfuCare Settles in Discrimination Lawsuit
Never Miss an Edition of BioMatrix Abstract!
BioMatrix is a nationwide, independently-owned infusion pharmacy with decades of experience supporting patients on specialty medication.